Dupont Capital Management Corp Ionis Pharmaceuticals Inc Transaction History

Dupont Capital Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	BUY	$36.54 - $48.66 $101,179 - $134,739	2,769 New	2,769 $122,000
Q3 2020 Oct 29, 2020	SELL	$47.45 - $62.95 $38,814 - $51,493	-818 Closed	0 $0
Q2 2020 Jul 24, 2020	BUY	$46.85 - $61.05 $38,323 - $49,938	818 New	818 $48,000
Q2 2018 Jul 30, 2018	SELL	$40.53 - $50.7 $320,227 - $400,580	-7,901 Closed	0 $0
Q3 2017 Oct 31, 2017	BUY	$45.56 - $59.57 $359,969 - $470,662	7,901	7,901 $401,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.83B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.